IL6 and plasma cell myeloma: For example, Salem K and colleagues have recently demonstrated that the combined treatment with the two chemotherapeutic drugs dexamethasone (Dex) and bortezomib (BTZ) attenuates paracrine IL-6 secretion from irradiated stromal cells, contributing to myeloma cell death and the inhibition of therapy resistance [42].